Superwise and NuevoSono Partner to Bring Trusted AI to Cardiac Care

In a move set to redefine how cardiologists see inside the human heart, enterprise AI governance leader Superwise has announced a strategic partnership with medical imaging innovator NuevoSono Inc. The collaboration, made public on Tuesday, aims to embed "trusted" and explainable AI directly into NuevoSono’s next-generation Intravascular Ultrasound (IVUS) platform.


This partnership addresses a critical bottleneck in cardiac care: while IVUS imaging provides life-saving views of coronary arteries, interpreting these complex images remains a highly specialized skill prone to variability. By adding a layer of governed AI, the companies hope to make "expert-level" analysis the standard for every procedure.

The "High-Res" Revolution
NuevoSono has been quietly disrupting the cath lab with a platform designed to eliminate the "clutter" of traditional systems.

Plug-and-Play Precision: Unlike legacy systems that require massive consoles on wheels, NuevoSono’s platform is described as a compact, "plug-and-play" solution. It is touted as the "world’s highest-resolution ultrasound system" for detecting coronary plaque.


The AI Upgrade: Through this deal, the platform will gain Superwise’s computer vision models. These algorithms will automatically identify vessel structures, highlight calcium deposits, and verify stent placement in real-time—acting as a second set of eyes for the interventional cardiologist.

Why "Trusted" AI Matters
The announcement emphasizes "Trusted AI"—a direct nod to the medical field's skepticism of "black box" algorithms that offer diagnoses without explanation.

Governance First: Superwise isn't just supplying the brain; it's supplying the conscience. The system utilizes Superwise’s Enterprise AI Governance and Operations platform to ensuring every AI suggestion is explainable, compliant with healthcare regulations (like HIPAA), and free from "hallucinations."

Operational Integrity: "From the start, making AI accessible to companies that improve lives has been central to our mission," said Russ Blattner, CEO of Superwise. The partnership ensures that the AI running inside a patient's artery is monitored as rigorously as the medical hardware itself.

Impact on Patient Care
For patients with Coronary Artery Disease (CAD), this technology could mean faster, safer procedures.

Democratizing Expertise: By automating complex image interpretation, the system helps less experienced physicians achieve the diagnostic accuracy of seasoned experts.

Workflow Efficiency: The integration is designed to be "hassle-free," removing the friction that often stops doctors from using IVUS in time-sensitive emergency procedures.